CN110721146A - Hydrolyzed embryo protein wrinkle-removing liquid and preparation method thereof - Google Patents
Hydrolyzed embryo protein wrinkle-removing liquid and preparation method thereof Download PDFInfo
- Publication number
- CN110721146A CN110721146A CN201910704875.2A CN201910704875A CN110721146A CN 110721146 A CN110721146 A CN 110721146A CN 201910704875 A CN201910704875 A CN 201910704875A CN 110721146 A CN110721146 A CN 110721146A
- Authority
- CN
- China
- Prior art keywords
- hydrolyzed
- protein
- embryo
- component
- following components
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a hydrolyzed embryo protein wrinkle-removing liquid and a preparation method thereof, wherein 20wt% of a component A and 80wt% of a component B are mixed, shaken and dissolved to form a mixed liquid; the component A comprises the following components in parts by weight: 95-97wt% of hydrolyzed embryonic protein, 1-2wt% of hydrolyzed protein, 1-1.5wt% of trehalose and 1-1.5wt% of collagen; the component B comprises the following components in parts by weight: 22-23.5wt% of rose water, 0.8-1wt% of fermentation product filtrate, 0.5-1wt% of tocopherol, 0.2-1wt% of soybean lecithin, 2-4wt% of gardenia liposome capsule and the balance of ionized water. Has the effects of activating cells, enabling the cells to have the capability of generating collagen and hyaluronic acid, further eliminating various wrinkles and improving the skin firmness.
Description
Technical Field
The invention relates to the technical field of wrinkle removing liquid, in particular to hydrolyzed embryo protein wrinkle removing liquid and a preparation method thereof.
Background
The physiological changes in the aging process of human body are mainly reflected in the loss of organism tissue cells and constitutional substances, the slowing of the metabolic rate of the organism, the reduction of the functions of the organism and organs and the prolonging of aging, which are the problems which people hope to solve urgently. Mesenchymal stem cells with high differentiation potential exist in human umbilical cords, and secretion of the mesenchymal stem cells contains various cytokines including epidermal growth factor, basic fibroblast growth factor, vascular endothelial growth factor, hepatocyte growth factor and the like. These different types of cytokines, although present in very low amounts in humans, can play a variety of important roles. For example: the different cytokines can promote the synthesis, metabolism, collagen synthesis and the like of skin cells of human beings, and are used in cosmetics or other health-care products under the condition of ensuring the activity of the cytokines, so that the cytokines are safe and have obvious anti-aging effect.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides the hydrolyzed embryo protein wrinkle-removing liquid and the preparation method thereof, which can protect the skin from being damaged, can activate cells to regenerate collagen by daily use, and has the effect of taking effect immediately for the face skin with various wrinkles.
In order to achieve the aim of the invention, the invention adopts the specific scheme that:
a hydrolyzed embryo protein wrinkle-removing solution is characterized in that 20wt% of component A and 80wt% of component B are mixed, shaken and dissolved to form a mixed solution;
the component A comprises the following components in parts by weight: 95-97wt% of hydrolyzed embryonic protein, 1-2wt% of hydrolyzed protein, 1-1.5wt% of trehalose and 1-1.5wt% of collagen;
the component B comprises the following components in parts by weight: 22-23.5wt% of rose water, 0.8-1wt% of fermentation product filtrate, 0.5-1wt% of tocopherol, 0.2-1wt% of soybean lecithin, 2-4wt% of gardenia liposome capsule and the balance of ionized water.
Further, the component A comprises the following components in parts by weight: 95wt% of hydrolyzed embryonic protein, 2wt% of hydrolyzed protein, 1.5wt% of trehalose and 1.5wt% of collagen;
the component B comprises the following components in parts by weight: 22wt% rose water, 0.8wt% fermentation product filtrate, 0.5wt% tocopherol, 0.2wt% soybean lecithin, 2wt% gardenia liposome, 74.5wt% ionized water.
Further, the component A comprises the following components in parts by weight: 96wt% of hydrolyzed embryonic protein, 1.5wt% of hydrolyzed protein, 1.2wt% of trehalose and 1.3wt% of collagen;
the component B comprises the following components in parts by weight: 23wt% rose water, 0.9wt% fermentation product filtrate, 0.8wt% tocopherol, 0.6wt% soybean lecithin, 3wt% gardenia liposome, 73.7 wt% ionized water.
Further, the component A comprises the following components in parts by weight: 97wt% of hydrolyzed embryonic protein, 1wt% of hydrolyzed protein, 1wt% of trehalose and 1wt% of collagen;
the component B comprises the following components in parts by weight: 23.5wt% of rose water, 1wt% of a filtrate of a fermentation product of the leuconostoc/radish root, 1wt% of tocopherol, 1wt% of soybean lecithin, 4wt% of gardenia microcapsules and 72.5wt% of ionized water.
Further, the method comprises the following steps:
(1) placing the prepared animal embryo without anticoagulant in a container or a test tube, covering, placing in an environment of-4 ℃ for waiting for the embryo to solidify, then sucking out the supernatant, storing in another container to obtain embryo protein, and refrigerating the obtained embryo protein at-8 ℃ until the embryo protein solidifies to obtain a solidified substance, thereby increasing the yield of the embryo protein;
(2) centrifuging the coagulum at 4000 rpm for 5 minutes;
(3) taking out the sample after the centrifugation is finished, observing the separation condition of the sample, and centrifuging once again until the upper layer embryo protein is clear if the upper layer embryo protein has coagulum floating, wherein the embryo cells are all tightly concentrated at the bottom of the centrifuge tube;
(4) sucking the secretion factor of the embryo protein on the upper layer by using a suction pipe, packaging by using a freezing storage container, and freezing and storing at the temperature of minus 4 ℃ to obtain the hydrolyzed embryo protein;
(5) taking out the hydrolyzed embryo protein from the freezing storage container, putting the hydrolyzed embryo protein in a 2-8C refrigerator to be in a half-dissolved state, taking the hydrolyzed embryo protein to room temperature to be completely dissolved, and regularly and uniformly shaking the hydrolyzed embryo protein in the room temperature dissolving process; the hydrolyzed embryonic protein cannot be placed at 37 ℃ for too long (not more than 30 minutes), if the hydrolyzed embryonic protein is placed at 37 ℃ for too long, the hydrolyzed embryonic protein becomes turbid, and simultaneously, a plurality of unstable components in the hydrolyzed embryonic protein are damaged, so that the quality of the hydrolyzed embryonic protein is influenced, and the activity of the hydrolyzed embryonic protein is maintained;
(6) at the moment, the embryo albumen is sticky, under the sterile and dry environment, 95-97wt% of hydrolyzed embryo albumen is taken, 1-2wt% of hydrolyzed albumen, 1-1.5wt% of trehalose and 1-1.5wt% of collagen are added, so that the sticky hydrolyzed embryo albumen can be adsorbed on various powders, the component A is obtained by uniformly stirring at the speed of 5r/min, and the hydrolyzed embryo albumen is kept dry;
(7) putting a certain amount of ionized water and 22-23.5wt% of rose water into an emulsifying machine, stirring and heating to 85 ℃ at the speed of 30r/min, keeping the temperature for 30 minutes, turning off heating equipment to reduce the internal temperature of the emulsifying machine to 45 ℃, sequentially adding 0.5-1wt% of tocopherol, 0.2-1wt% of soybean lecithin, 0.8-1wt% of leuconostoc/radish root fermentation product filtrate and 2-4wt% of gardenia liposome capsules every 10 minutes, continuously stirring for 5 minutes at the speed of 30r/min to obtain a component B, wherein the mixed product is a penetrating fluid and is easier to penetrate into the bottom layer of the skin;
(8) mixing 20wt% of component A and 80wt% of component B, shaking and dissolving to form mixed solution, which can dissolve serum protein and can bring active substances into hair follicle cells.
Further, the total content of the hydrolyzed embryonic protein, the hydrolyzed protein, the trehalose and the collagen in the step (6) is 100 wt%.
Further, in the step (8), the total content of the gardenia liposome in the ionized water, the rose water, the tocopherol, the soybean lecithin and the leuconostoc/radish root fermentation product filtrate is 100 wt%.
The invention has the beneficial effects that:
hydrolyzing embryo protein: the english name plutipene refers to a pale yellow transparent liquid separated by removing fibrin in the process after the embryo is coagulated or to an embryo from which fibrin has been removed. The main functions of the nutrient solution are to provide basic nutrients, provide various growth factors and binding proteins, provide contact promoting and stretching factors to prevent cells from adhering to the wall from mechanical damage, protect the cells in culture and activate the cells. Hydrolyzing protein: the hydrolyzed protein is prepared from casein or blood fiber by acid hydrolysis or enzymolysis, and is light yellow or nearly gray yellow block or granule; it is deliquescent and has special odor, but it should not have putrefactive odor. Can be dissolved in water. The amino nitrogen content should be more than 50% of the total nitrogen (N). Provides necessary amino acid for the anabolism of the organism so as to maintain the balance of nitrogen in the body and provide a cell moistening effect. Trehalose: a special protective film can be formed on the cell surface layer, mucus precipitated from the film not only moistens skin cells, but also has the function of radiating external heat, thereby protecting the skin from being damaged; can effectively protect the epidermal cell membrane structure, activate cells, condition the skin, make the skin healthy, natural and elastic and soften the skin tissues around the cells. Collagen protein: collagen is a biological macromolecule, the main component in the connective tissue of animals, and is also the functional protein with the largest content and the widest distribution in the mammalian body, because the collagen has good biocompatibility, biodegradability and bioactivity, the collagen has a structure similar to the collagen of human skin, is water-insoluble fibrous glycoprotein, contains a large amount of amino acids and hydrophilic groups in the molecule, has certain surface activity and good compatibility, and because the molecule contains a large amount of hydroxyl, the collagen has quite good moisturizing effect and activates the elasticity of cells. Ionized water: the water purifier filters tap water by using active carbon as a filter layer to ensure that the tap water is purified to reach the standard, and then two kinds of active water are generated by electrolyzing through a diaphragm. Rose water: is the water solution distilled off when distilling the rose essential oil. The water contains 0.02-0.03% of rose essential oil and various water-soluble effective components such as protein, tannin, cyclic peptide, etc. in flos Rosae Rugosae. Can be used as moisturizing toner for keeping skin elasticity and vitality. Fermentation product filtrate: a skin conditioning agent; an antibacterial agent. The method comprises the steps of separating the peptide with antimicrobial activity from the Leuconostoc leucocephala of Korean kimchi by using modern technologies, and simultaneously satisfying the requirements of natural ingredients and peptide; has strong killing and inhibiting effects on staphylococcus aureus, escherichia coli, pseudomonas aeruginosa, candida albicans, aspergillus niger, klebsiella pneumoniae and bukholderia cepacia; is suitable for wide pH value range. Is a preservative substitute with skin conditioning effect. Can be used in product for treating sensitive skin and acne. And (3) tocopherol: tocopherols are hydrolysates of vitamin e (ve), a natural oil-soluble antioxidant currently produced in large quantities. Increasing cell antioxidation, and maintaining and promoting reproductive function. Soybean lecithin: is a byproduct in the process of refining soybean oil, and is obtained by solvent extraction, centrifugal separation and alcohol washing. The cell membrane is mainly composed of lecithin, and the supplementation of lecithin to human body means that the damaged cell membrane can be repaired, the cell membrane function can be improved, the cell membrane can be softened and younger, and the cell activity can be increased. The intake of lecithin can improve the metabolic capability, self-healing capability and regeneration capability of antibody tissues of human bodies. The gardenia liposome is a nano product obtained by a packaging technology, can effectively and directly permeate effective factors to the bottommost layer of the skin, and is favorable for absorption of cells. The wrinkle-removing liquid has the functions of activating cells, enabling the cells to have the capacity of generating collagen and hyaluronic acid, further eliminating various wrinkles and improving the skin firmness.
Drawings
FIG. 1 is a comparison of a front and a back view of a product of the invention;
FIG. 2 is a comparison of the front and back of a product of the invention;
FIG. 3 is a comparison of the front and back of a product using the invention;
FIG. 4 is a comparison of the front and back of a product using the invention;
FIG. 5 is a comparison of the front and back of a product using the invention;
FIG. 6 is a comparison of the front and back of a product using the invention;
FIG. 7 is a comparison of the front and back of a product using the invention.
Detailed Description
The present invention is further described below by way of specific examples, but the present invention is not limited to only the following examples. Variations, combinations, or substitutions of the invention, which are within the scope of the invention or the spirit, scope of the invention, will be apparent to those of skill in the art and are within the scope of the invention.
In order to make the content of the present invention more clearly understood, the technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention.
Example 1:
a wrinkle removing solution of hydrolyzed embryo protein is prepared by mixing 20wt% of component A and 80wt% of component B, shaking and dissolving to form mixed solution;
the component A comprises the following components in parts by weight: 95wt% of hydrolyzed embryonic protein, 2wt% of hydrolyzed protein, 1.5wt% of trehalose and 1.5wt% of collagen;
the component B comprises the following components in parts by weight: 22wt% of rose water, 0.8wt% of a filtrate of a fermentation product of the leuconostoc/radish root, 0.5wt% of tocopherol, 0.2wt% of soybean lecithin, 2wt% of gardenia microcapsules and 74.5wt% of ionized water.
A method for preparing a hydrolyzed embryo protein wrinkle-removing liquid comprises the following steps:
(1) placing the prepared animal embryo without anticoagulant in a container or a test tube, covering, placing in an environment of-4 deg.C for embryo coagulation, sucking out the supernatant, storing in another container to obtain embryo, and refrigerating the obtained serum at-8 deg.C until coagulation to obtain coagulum;
(2) centrifuging the coagulum at 4000 rpm for 5 minutes;
(3) taking out the sample after the centrifugation is finished, observing the separation condition of the sample, and centrifuging once again until the upper layer embryo protein is clear if the upper layer embryo protein has coagulum floating, wherein the embryo cells are all tightly concentrated at the bottom of the centrifuge tube;
(4) sucking the embryo secretion factor at the upper layer by a suction pipe, packaging by a freezing storage container, and freezing and storing at-4 ℃ to obtain hydrolyzed embryo protein;
(5) taking out the hydrolyzed embryo protein from the freezing storage container, putting the hydrolyzed embryo protein in a 2-8C refrigerator to be in a half-dissolved state, taking the hydrolyzed embryo protein to room temperature to be completely dissolved, and regularly and uniformly shaking the hydrolyzed embryo protein in the room temperature dissolving process;
(6) at the moment, the embryo is sticky, under the sterile and dry environment, 95wt% of hydrolyzed embryo protein is taken, 2wt% of hydrolyzed protein, 1.5wt% of trehalose and 1.5wt% of collagen are added, so that the sticky hydrolyzed embryo protein can be adsorbed on various powder, and the component A is obtained by uniformly stirring at the speed of 5 r/min;
(7) putting a certain amount of ionized water and 22wt% of rose water into an emulsifying machine, stirring and heating to 85 ℃ at the speed of 30r/min, keeping the temperature for 30 minutes, turning off heating equipment to reduce the internal temperature of the emulsifying machine to 45 ℃, sequentially adding 0.5wt% of tocopherol, 0.2wt% of soybean lecithin, 0.8% of leuconostoc/radish root fermentation product filtrate and 2wt% of gardenia liposome capsules every 10 minutes, and continuously stirring for 5 minutes at the speed of 30r/min to obtain a component B;
(8) the mixture is formed by mixing 20wt% of the component A and 80wt% of the component B and shaking for dissolution.
The total content of the hydrolyzed embryonic protein, the hydrolyzed protein, the trehalose and the collagen in the step (6) is 100 wt%.
In the step (8), the total content of 2wt% of gardenia lipid vesicles in the ionized water, rose water, tocopherol, soybean lecithin and leuconostoc/radish root fermentation product filtrate is 100 wt%.
Example 2:
a wrinkle removing solution of hydrolyzed embryo protein is prepared by mixing 20wt% of component A and 80wt% of component B, shaking and dissolving to form mixed solution;
the component A comprises the following components in parts by weight: 96wt% of hydrolyzed embryonic protein, 1.5wt% of hydrolyzed protein, 1.2wt% of trehalose and 1.3wt% of collagen;
the component B comprises the following components in parts by weight: 23wt% of rose water, 0.9wt% of a filtrate of a fermentation product of leuconostoc/radish root, 0.8wt% of tocopherol, 0.6wt% of soybean lecithin, 3wt% of gardenia microcapsules, and 73.7 wt% of ionized water
A method for preparing a hydrolyzed embryo protein wrinkle-removing liquid comprises the following steps:
(1) placing the prepared animal embryo without anticoagulant in a container or a test tube, covering, placing in an environment of-4 ℃ for embryo coagulation, then sucking out the supernatant, storing in another container to obtain an embryo, and refrigerating the embryo at-8 ℃ until the embryo is coagulated to obtain a coagulum;
(2) centrifuging the coagulum at 4000 rpm for 5 minutes;
(3) taking out the sample after the centrifugation is finished, observing the separation condition of the sample, and centrifuging once again until the upper layer embryo is clear if the upper layer embryo has coagulum floating, wherein the embryo cells are all tightly concentrated at the bottom of the centrifuge tube;
(4) sucking the embryo secretion factor at the upper layer by a suction pipe, packaging by a freezing storage container, and freezing and storing at-4 ℃ to obtain hydrolyzed embryo protein;
(5) taking out the hydrolyzed embryo protein from the freezing storage container, putting the hydrolyzed embryo protein in a 2-8C refrigerator to be in a half-dissolved state, taking the hydrolyzed embryo protein to room temperature to be completely dissolved, and regularly and uniformly shaking the hydrolyzed embryo protein in the room temperature dissolving process;
(6) at the moment, the embryo albumen is sticky, under the sterile and dry environment, 96wt% of hydrolyzed embryo albumen is taken, 1.5wt% of hydrolyzed albumen, 1.2wt% of trehalose and 1.3wt% of collagen are added, so that the sticky hydrolyzed embryo albumen can be adsorbed on various powder bodies, and the component A is obtained by uniformly stirring at the speed of 5 r/min;
(7) putting a certain amount of ionized water and 23wt% of rose water into an emulsifying machine, stirring and heating to 85 ℃ at the speed of 30r/min, keeping the temperature for 30 minutes, turning off heating equipment to reduce the internal temperature of the emulsifying machine to 45 ℃, sequentially adding 0.8wt% of tocopherol, 0.6wt% of soybean lecithin, 0.9wt% of leuconostoc/common turnip fermentation product filtrate and 3wt% of gardenia liposome capsules at the speed of 30r/min, and continuously stirring for 5 minutes to obtain a component B;
(8) the mixture is formed by mixing 20wt% of the component A and 80wt% of the component B and shaking for dissolution.
The total content of the hydrolyzed embryonic protein, the hydrolyzed protein, the trehalose and the collagen in the step (6) is 100 wt%.
In the step (8), the total content of the gardenia liposome is 100 wt% in ionized water, rose water, tocopherol, soybean lecithin and a filtrate of a leuconostoc/radish root fermentation product.
Example 3:
a wrinkle removing solution of hydrolyzed embryo protein is prepared by mixing 20wt% of component A and 80wt% of component B, shaking and dissolving to form mixed solution;
the component A comprises the following components in parts by weight: 97wt% of hydrolyzed embryonic protein, 1wt% of hydrolyzed protein, 1wt% of trehalose and 1wt% of collagen;
the component B comprises the following components in parts by weight: 23.5wt% of rose water, 1wt% of a filtrate of a fermentation product of the leuconostoc/radish root, 1wt% of tocopherol, 1wt% of soybean lecithin, and 4wt% of gardenia liposome capsules 72.5wt% of ionized water.
A method for preparing a hydrolyzed embryo protein wrinkle-removing liquid comprises the following steps:
(1) placing the prepared animal embryo without anticoagulant in a container or a test tube, covering, placing in an environment of-4 ℃ for embryo coagulation, then sucking out the supernatant, storing in another container to obtain the required embryo, and refrigerating the embryo at-8 ℃ until the embryo is coagulated to obtain a coagulum;
(2) centrifuging the coagulum at 4000 rpm for 5 minutes;
(3) taking out the sample after the centrifugation is finished, observing the separation condition of the sample, and centrifuging once again until the upper layer embryo is clear if the upper layer embryo has coagulum floating, wherein blood cells are all tightly concentrated at the bottom of the centrifuge tube;
(4) sucking the embryo secretion factor at the upper layer by a suction pipe, packaging by a freezing storage container, and freezing and storing at-4 ℃ to obtain hydrolyzed embryo protein;
(5) taking out the hydrolyzed embryo protein from the freezing storage container, putting the hydrolyzed embryo protein in a 2-8C refrigerator to be in a half-dissolved state, taking the hydrolyzed embryo protein to room temperature to be completely dissolved, and regularly and uniformly shaking the hydrolyzed embryo protein in the room temperature dissolving process;
(6) at the moment, the embryo is sticky, 97wt% of hydrolyzed embryo protein is taken out under the sterile and dry environment, 1wt% of hydrolyzed protein, 1wt% of trehalose and 1wt% of collagen are added, so that the sticky hydrolyzed serum protein can be adsorbed on various powder, and the component A is obtained by uniformly stirring at the speed of 5 r/min;
(7) putting a certain amount of ionized water and 23.5wt% of rose water into an emulsifying machine, stirring and heating to 85 ℃ at the speed of 30r/min, keeping the temperature for 30 minutes, turning off heating equipment to reduce the internal temperature of the emulsifying machine to 45 ℃, sequentially adding 1wt% of tocopherol, 1wt% of soybean lecithin, 1wt% of leuconostoc/radish root fermentation product filtrate and 4wt% of gardenia liposome capsules at the speed of 30r/min, and continuously stirring for 5 minutes to obtain a component B;
(8) the mixture is formed by mixing 20wt% of the component A and 80wt% of the component B and shaking for dissolution.
The total content of the hydrolyzed embryonic protein, the hydrolyzed protein, the trehalose and the collagen in the step (6) is 100 wt%.
In the step (8), the total content of the gardenia liposome is 100 wt% in ionized water, rose water, tocopherol, soybean lecithin and a filtrate of a leuconostoc/radish root fermentation product.
By adopting the scheme of the embodiment 1-3, the experiment takes 40 people as one group, and the total number of the people is 6, the people with the age of 30-60 years and the symptoms of fishtail lines, splayed lines, raised lines and facial muscle relaxation. The first and second groups used the protocol of example 1, the third and fourth groups used the protocol of example 2, and the fifth and sixth groups used the protocol of example 3 by spraying the product on the face and massaging with fingers, once a day, in the morning and evening, for three months.
Crow's feet line splayed line facial muscle relaxation cure rate recurrence rate
The first group of lines can reduce the lines, the lines become light, and the tightening effect is obviously 99 percent to 1 percent
The second group of lines can reduce the lines, obviously has the tightening effect of 98 percent and 1.2 percent
The third group of lines has the effect of reducing the lines, obviously reducing the lines and tightening the lines by 96 percent to 1.5 percent
The fourth group of lines has the effect of reducing the lines, obviously reducing the lines and tightening the lines by 95 percent to 1.8 percent
The fifth group of lines has the effect of reducing lines, obviously reducing the lines and obviously compacting 93 percent to 2 percent
The sixth group of lines has the effects of reducing lines, obviously tightening the lines and obviously tightening the lines by 90 percent to 2.2 percent
The embryo protein factor is directly used for activating, repairing and regenerating cells so as to achieve the effect of removing wrinkles.
The practical effects of the invention are as follows:
as shown in figure 1, in the male, the male is 45 years old and used for three months and days, the lines in the first month are obviously reduced, the wrinkles in the third month are obviously eliminated, and meanwhile, the skin has a remarkable tightening effect.
As shown in fig. 2, in men, the age of 52 years is three months and a day, and after 3 months, the fishtail line is obviously disappeared.
As shown in figure 3, in the male, 55 years old, the crow's feet were obvious before use, and the crow's feet were improved after continuous use for 5 weeks.
As shown in FIG. 4, when the female is aged 54 years and used for half a month a day, the lower eye wrinkles are obviously reduced.
As shown in FIG. 5, in a male, 54 years old, Hangzhou, who was used a month and a day, wrinkles on the face due to muscle relaxation were significantly improved, and the elasticity of the muscles was significantly increased.
As shown in figure 6, when the female is 68 years old and Taipei people are used for 2 months and days, the neck relaxation muscles obviously improve the lines and obviously reduce the lines.
As shown in fig. 7, in women, 45 years old, senior male, and 5 worship days, the fishtail line gradually fades from the original depth to be smooth and elastic.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the present invention, and any modifications, equivalents and improvements made within the spirit and principle of the present invention should be included in the scope of the present invention.
Claims (7)
1. A hydrolyzed embryo protein wrinkle-removing solution is characterized in that 20wt% of component A and 80wt% of component B are mixed, shaken and dissolved to form a mixed solution;
the component A comprises the following components in parts by weight: 95-97wt% of hydrolyzed embryonic protein, 1-2wt% of hydrolyzed protein, 1-1.5wt% of trehalose and 1-1.5wt% of collagen;
the component B comprises the following components in parts by weight: 22-23.5wt% of rose water, 0.8-1wt% of fermentation product filtrate, 0.5-1wt% of tocopherol, 0.2-1wt% of soybean lecithin, 2-4wt% of gardenia liposome capsule and the balance of ionized water.
2. The hydrolyzed embryo protein wrinkle-removing liquid as claimed in claim 1, wherein the component A comprises the following components in parts by weight: 95wt% of hydrolyzed embryonic protein, 2wt% of hydrolyzed protein, 1.5wt% of trehalose and 1.5wt% of collagen;
the component B comprises the following components in parts by weight: 22wt% rose water, 0.8wt% fermentation product filtrate, 0.5wt% tocopherol, 0.2wt% soybean lecithin, 2wt% gardenia liposome, 74.5wt% ionized water.
3. The hydrolyzed embryo protein wrinkle-removing liquid as claimed in claim 1, wherein the component A comprises the following components in parts by weight: 96wt% of hydrolyzed embryonic protein, 1.5wt% of hydrolyzed protein, 1.2wt% of trehalose and 1.3wt% of collagen;
the component B comprises the following components in parts by weight: 23wt% rose water, 0.9wt% fermentation product filtrate, 0.8wt% tocopherol, 0.6wt% soybean lecithin, 3wt% gardenia liposome, 73.7 wt% ionized water.
4. The hydrolyzed embryo protein wrinkle-removing liquid as claimed in claim 1, wherein the component A comprises the following components in parts by weight: 97wt% of hydrolyzed embryonic protein, 1wt% of hydrolyzed protein, 1wt% of trehalose and 1wt% of collagen;
the component B comprises the following components in parts by weight: 23.5wt% rose water, 1wt% fermentation product filtrate, 1wt% tocopherol, 1wt% soybean lecithin, 4wt% gardenia liposome, 72.5wt% ionized water.
5. A method for preparing the hydrolyzed embryo wrinkle-removing liquid according to any one of claims 1 to 4, comprising the following steps:
(1) placing the prepared animal embryo without anticoagulant in a container or a test tube, covering, placing in an environment of-4 ℃ for waiting for the embryo to be coagulated, then sucking out the supernatant, storing in another container to obtain embryo protein, and refrigerating the embryo protein at-8 ℃ until the embryo protein is coagulated to obtain a coagulum;
(2) centrifuging the coagulum at 4000 rpm for 5 minutes;
(3) taking out the sample after the centrifugation is finished, observing the separation condition of the sample, and centrifuging once again until the upper layer embryo protein is clear if the upper layer embryo protein has coagulum floating, wherein the embryo cells are all tightly concentrated at the bottom of the centrifuge tube;
(4) sucking the secretion factor of the embryo protein on the upper layer by using a suction pipe, packaging by using a freezing storage container, and freezing and storing at the temperature of minus 4 ℃ to obtain the hydrolyzed embryo protein;
(5) taking out the hydrolyzed embryo protein from the freezing storage container, putting the hydrolyzed embryo protein in a 2-8C refrigerator to be in a half-dissolved state, taking the hydrolyzed embryo protein to room temperature to be completely dissolved, and regularly and uniformly shaking the hydrolyzed embryo protein in the room temperature dissolving process;
(6) at the moment, the embryo albumen is sticky, under the sterile and dry environment, 95-97wt% of hydrolyzed embryo albumen is taken, 1-2wt% of hydrolyzed albumen, 1-1.5wt% of trehalose and 1-1.5wt% of collagen are added, so that the sticky hydrolyzed embryo albumen can be adsorbed on various powders, and the component A is obtained by uniformly stirring at the speed of 5 r/min;
(7) putting a certain amount of ionized water and 22-23.5wt% of rose water into an emulsifying machine, stirring and heating to 85 ℃ at the speed of 30r/min, keeping the temperature for 30 minutes, turning off heating equipment to reduce the internal temperature of the emulsifying machine to 45 ℃, sequentially adding 0.5-1wt% of tocopherol, 0.2-1wt% of soybean lecithin, 0.8-1wt% of leuconostoc/radish root fermentation product filtrate and 2-4wt% of gardenia liposome capsules every 10 minutes, and continuously stirring for 5 minutes at the speed of 30r/min to obtain a component B;
(8) the mixture is formed by mixing 20wt% of the component A and 80wt% of the component B and shaking for dissolution.
6. The method for preparing the wrinkle-removing liquid of hydrolyzed embryonic protein as claimed in claim 5, wherein the total content of the hydrolyzed embryonic protein, the hydrolyzed protein, the trehalose and the collagen in the step (6) is 100 wt%.
7. The method of claim 5, wherein the ionic water, rose water, tocopherol, soy lecithin, and Leuconostoc/Raphanus sativus fermentation product filtrate in the step (8) have a total content of gardenia liposome 100 wt%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910704875.2A CN110721146A (en) | 2019-08-01 | 2019-08-01 | Hydrolyzed embryo protein wrinkle-removing liquid and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910704875.2A CN110721146A (en) | 2019-08-01 | 2019-08-01 | Hydrolyzed embryo protein wrinkle-removing liquid and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110721146A true CN110721146A (en) | 2020-01-24 |
Family
ID=69217716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910704875.2A Pending CN110721146A (en) | 2019-08-01 | 2019-08-01 | Hydrolyzed embryo protein wrinkle-removing liquid and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110721146A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115708798A (en) * | 2023-01-10 | 2023-02-24 | 昆明时光肌生物技术有限公司 | One-step hydrolysis preparation method of sheep placenta extract |
-
2019
- 2019-08-01 CN CN201910704875.2A patent/CN110721146A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115708798A (en) * | 2023-01-10 | 2023-02-24 | 昆明时光肌生物技术有限公司 | One-step hydrolysis preparation method of sheep placenta extract |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1052307A (en) | Method for the extraction and processing of glycoproteins, mucopolysaccharides and accompanying substances | |
CN109512691A (en) | A kind of indigo plant copper peptide freeze-dried powder preparation and preparation method thereof | |
KR100828494B1 (en) | Cosmetic essence composition for skin wrinkle improvement and composition method thereof | |
CN107929091A (en) | A kind of extracting method of high activity collagen and its application | |
CN104041831B (en) | A kind of tree peony polypeptide soft capsule and preparation method thereof | |
US20220287952A1 (en) | Compositions containing exosomes from animal placenta, methods for producing the same and uses thereof | |
CN110538312A (en) | A skin wound repair ointment and preparation method thereof | |
CN101648018A (en) | Medicinal composition for treating ophthalmic inflammation and application thereof | |
CN101020715B (en) | Process of extracting and preparing deer nerve growth factor (DEER NGF) | |
CN106432541A (en) | Method for extracting sturgeon cartilage extract | |
CN104163847A (en) | Housefly larvae active protein peptide preparation method and housefly larvae active protein peptide prepared thereby and purpose of housefly larvae active protein peptide | |
EP0237398B1 (en) | Use of biologically active polypeptides and compositions containing them | |
CN110721146A (en) | Hydrolyzed embryo protein wrinkle-removing liquid and preparation method thereof | |
CN102908366A (en) | Preparation method of chick embryo active component | |
US20200405613A1 (en) | Application of rat tail collagen in field of cosmetics | |
EP2730586B1 (en) | Protein-polypeptide complex obtained from tissues of hoofed livestock embryos, process for preparing same and pharmaceutical composition | |
CN113304098A (en) | Facial mask essence containing stem cell extracting solution and facial mask | |
CN114099544A (en) | Preparation method of autologous venous blood cell activator | |
JPH0665041A (en) | Skin external preparation | |
CN110123690A (en) | A kind of hydrolyzed serum protein hair growth liquor and preparation method thereof | |
JP3172599B2 (en) | Cell activator | |
CN118178300B (en) | Preparation of anti-wrinkle and moisturizing freeze-dried powder composition | |
KR102623104B1 (en) | A cosmetic composition for skin regeneration and wrinkle improvement containing botulinum toxin conjugates and stem cell exosome complexes as active ingredients, and a method of manufacturing the same | |
CN109010367A (en) | Bovine colostrum and preparation method thereof, preparation and the application in preparation tumor | |
JP7423780B2 (en) | Method for producing purified Salacia plant extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200124 |
|
RJ01 | Rejection of invention patent application after publication |